Literature DB >> 20589939

The effect of pulmonary hypertension on left ventricular diastolic function in chronic obstructive lung disease: a tissue Doppler imaging and right cardiac catheterization study.

Mahmut Acikel1, Nuri Kose, Alpay Aribas, Hasan Kaynar, Serdar Sevimli, Yekta Gurlertop, M Kemal Erol.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) caused by chronic obstructive lung disease (COLD) essentially involves the right heart. Also left ventricular (LV) systolic and diastolic functions may be affected.
OBJECTIVES: The aim of this study was to investigate the effect of on LV diastolic function in patients with COLD.
METHODS: A total of 47 patients with COLD and 20 controls were included in this study. All patients underwent Doppler echocardiography, tissue Doppler imaging examinations and right cardiac catheterization. The patients were divided into 2 subgroups according to mean pulmonary arterial pressure (mPAP): patients without PH (group1, n = 25) and with PH (group 2, n = 22). The following measurements were taken: peak velocity of early diastolic filling (E), peak late filling with atrial contraction (A), E/A ratio, deceleration time (DT) of E, isovolumic relaxation time (IVRT), early (Em) and late (Am) diastolic mitral lateral annulus velocity.
RESULTS: Mitral E/A < 1 and Em < 8 cm/sec were higher in group 2 than in group 1 and the control group. There were significant correlations between mPAP and both mitral E/A (r:- 0.60) and Em (r:- 0.45). In multivariate model, mPAP was not found to be significant on mitral E/A ratio < 1, but there was a significant effect on mitral Em < 8 cm/sec (odds ratio [OR]:1.14, P < 0.05).
CONCLUSION: This study shows that LV diastolic dysfunction in COLD is closely correlated to PH levels. Although increased mPAP may affect the mitral E/A ratio, it seems to have no effect on mitral E/A < 1, whereas it has an independent effect on Em < 8 cm/sec.

Entities:  

Mesh:

Year:  2010        PMID: 20589939      PMCID: PMC6652991          DOI: 10.1002/clc.20568

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  7 in total

1.  Contributions of pulmonary hypertension to HIV-related cardiac dysfunction.

Authors:  Godsent C Isiguzo; Basil N Okeahialam; Solomon S Danbauchi; Augustine N Odili; Michael O Iroezindu; Ugoagwu Placid
Journal:  Indian Heart J       Date:  2013-09-02

2.  Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.

Authors:  Sulaiman Surie; Herre J Reesink; J Tim Marcus; Mart N van der Plas; Jaap J Kloek; Anton Vonk-Noordegraaf; Paul Bresser
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

3.  Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease.

Authors:  Mikkel Malby Schoos; Morten Dalsgaard; Jesper Kjærgaard; Dorte Moesby; Sidse Graff Jensen; Ida Steffensen; Kasper Karmark Iversen
Journal:  BMC Cardiovasc Disord       Date:  2013-10-12       Impact factor: 2.298

4.  Left Ventricular Diastolic Function Assessment of a Heterogeneous Cohort of Pulmonary Arterial Hypertension Patients.

Authors:  Dagmar F Hernandez-Suarez; Francisco R Lopez Menendez; Denada Palm; Angel Lopez-Candales
Journal:  J Clin Med Res       Date:  2017-02-21

Review 5.  The Role of Echocardiography in Neonates and Pediatric Patients on Extracorporeal Membrane Oxygenation.

Authors:  Carles Bautista-Rodriguez; Joan Sanchez-de-Toledo; Eduardo M Da Cruz
Journal:  Front Pediatr       Date:  2018-10-26       Impact factor: 3.418

6.  Concordance between Doppler and pulsed-wave Doppler tissue imaging in estimation of the degree of left ventricular dysfunction and correlating it to the degree of chronic obstructive pulmonary disease.

Authors:  Inas Eweda; Ghada Hamada
Journal:  J Saudi Heart Assoc       Date:  2015-04-27

Review 7.  Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD.

Authors:  J Michael Wells; Mark T Dransfield
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.